New Laboratory of Industrial Fluidic Translation (LIFT) to Develop Microfluidic Device Tests for the Diagnostic Market

Share Article

Cryopak Canada and Launchworks Manufacturing Lab are announcing a collaboration with the National Research Council of Canada (NRC) to create the Laboratory of Industrial Fluidic Translation (LIFT).

Cryopak Canada and Launchworks Manufacturing Lab are announcing a collaboration with the National Research Council of Canada (NRC) to create the Laboratory of Industrial Fluidic Translation (LIFT).

New Laboratory of Industrial Fluidic Translation (LIFT) to Develop Microfluidic Device Tests for the Diagnostic Market

"The NRC’s 20 years of experience in scientific development combined with Launchworks ISO 13485 manufacturing capabilities will provide point-of-care diagnostic companies a complete and cost-effective service solution,” said Jeff Kelly, VP of Corporate Development for Cryopak.

Cryopak Canada and Launchworks Manufacturing Lab are announcing a collaboration with the National Research Council of Canada (NRC) to create the Laboratory of Industrial Fluidic Translation (LIFT). By joining their knowledge in nanofabrication and lab-on-a-chip technologies and in manufacturing, LIFT will offer a competitive capacity to accelerate the creation, certification and deployment of microfluidic bio-devices, a one-stop shop expertise and service not available in North America.

LIFT will support the diagnostic device industry’s objectives by combining the NRC’s expertise in sciences, materials, and design with Launchworks’ expertise in cGMP and ISO 13485 manufacturing at clinical and industrial scale. Through this partnership, the organizations will work with diagnostic companies to translate microfluidic application ideas into workable devices.

“Microfluidic diagnostic companies are driving device development to be faster, easier to use and more cost effective,” said Jeff Kelly, VP of Corporate Development for Cryopak. “The NRC’s 20 years of experience in scientific development combined with Launchworks ISO 13485 manufacturing capabilities will provide point-of-care diagnostic companies a complete and cost-effective service solution to rapidly bring their ideas to successful commercialization.”

Design and development will be done at the NRC in Montréal, with manufacturing to be done initially at the LaunchWorks facility in Beverly, MA, and plans to develop an additional manufacturing facility with Cryopak Canada in the near future. Cryopak and LaunchWorks are affiliate companies both owned by TCP Reliable.

For further information, please visit http://www.LaunchWorksML.com, http://www.cryopak.ca, or https://nrc.canada.ca/en

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gael Peron
Visit website